These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

860 related items for PubMed ID: 1718596

  • 1. Characterization of human autotumor-reactive T-cell clones obtained from tumor-infiltrating lymphocytes in liver metastasis of gastric carcinoma.
    Shimizu Y, Weidmann E, Iwatsuki S, Herberman RB, Whiteside TL.
    Cancer Res; 1991 Nov 15; 51(22):6153-62. PubMed ID: 1718596
    [Abstract] [Full Text] [Related]

  • 2. Human cytotoxic T-cell lines with restricted specificity for squamous cell carcinoma of the head and neck.
    Yasumura S, Hirabayashi H, Schwartz DR, Toso JF, Johnson JT, Herberman RB, Whiteside TL.
    Cancer Res; 1993 Mar 15; 53(6):1461-8. PubMed ID: 8443824
    [Abstract] [Full Text] [Related]

  • 3. T-cell receptor V beta gene usage of human cytotoxic T-cell clones obtained from gastric cancer patients.
    Miyahara E, Yamaguchi Y, Minami K, Hihara J, Noma K, Toge T, Takafuta T, Fujimura K.
    Anticancer Res; 1999 Mar 15; 19(3A):2057-66. PubMed ID: 10470148
    [Abstract] [Full Text] [Related]

  • 4. Interactions between autologous CD4+ and CD8+ T lymphocytes and human squamous cell carcinoma of the head and neck.
    Okada K, Yasumura S, Muller-Fleckenstein I, Fleckenstein B, Talib S, Koldovsky U, Whiteside TL.
    Cell Immunol; 1997 Apr 10; 177(1):35-48. PubMed ID: 9140094
    [Abstract] [Full Text] [Related]

  • 5. Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity.
    de Vries JE, Spits H.
    J Immunol; 1984 Jan 10; 132(1):510-9. PubMed ID: 6197458
    [Abstract] [Full Text] [Related]

  • 6. Selective expansion of a specific anti-tumor CD8+ cytotoxic T lymphocyte clone in the bulk culture of tumor-infiltrating lymphocytes from a melanoma patient: cytotoxic activity and T cell receptor gene rearrangements.
    Gervois N, Heuze F, Diez E, Jotereau F.
    Eur J Immunol; 1990 Apr 10; 20(4):825-31. PubMed ID: 1971794
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Major histocompatibility complex-unrestricted cytolytic activity of human T cells. Analysis of precursor frequency and effector phenotype.
    Patel SS, Thiele DL, Lipsky PE.
    J Immunol; 1987 Dec 01; 139(11):3886-95. PubMed ID: 3500232
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Tumor cytolysis by lymphocytes infiltrating ovarian malignant ascites.
    Ioannides CG, Platsoucas CD, Rashed S, Wharton JT, Edwards CL, Freedman RS.
    Cancer Res; 1991 Aug 15; 51(16):4257-65. PubMed ID: 1868446
    [Abstract] [Full Text] [Related]

  • 11. Specificity of human T lymphocytes expressing a gamma/delta T cell antigen receptor. Recognition of a polymorphic determinant of HLA class I molecules by a gamma/delta clone.
    Ciccone E, Viale O, Pende D, Malnati M, Battista Ferrara G, Barocci S, Moretta A, Moretta L.
    Eur J Immunol; 1989 Jul 15; 19(7):1267-71. PubMed ID: 2527158
    [Abstract] [Full Text] [Related]

  • 12. Defective lymphokine production by most CD8+ and CD4+ tumor-specific T cell clones derived from human melanoma-infiltrating lymphocytes in response to autologous tumor cells in vitro.
    Guilloux Y, Viret C, Gervois N, Le Dréan E, Pandolfino MC, Diez E, Jotereau F.
    Eur J Immunol; 1994 Sep 15; 24(9):1966-73. PubMed ID: 7522155
    [Abstract] [Full Text] [Related]

  • 13. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. I. Lysis restricted by HLA class II MB and DR antigens.
    Yasukawa M, Zarling JM.
    J Immunol; 1984 Jul 15; 133(1):422-7. PubMed ID: 6609990
    [Abstract] [Full Text] [Related]

  • 14. Antigen specific and MHC nonrestricted cytotoxicity of T cell receptor alpha beta+ and gamma delta+ human T cell clones isolated in IL-4.
    Paliard X, Yssel H, Blanchard D, Waitz JA, deVries JE, Spits H.
    J Immunol; 1989 Jul 15; 143(2):452-7. PubMed ID: 2472439
    [Abstract] [Full Text] [Related]

  • 15. Lysis of tumor cells by CD3+4-8-16+ T cell receptor alpha beta- clones, regulated via CD3 and CD16 activation sites, recombinant interleukin 2, and interferon beta 1.
    van de Griend RJ, Tax WJ, van Krimpen BA, Vreugdenhil RJ, Ronteltap CP, Bolhuis RL.
    J Immunol; 1987 Mar 01; 138(5):1627-33. PubMed ID: 2949018
    [Abstract] [Full Text] [Related]

  • 16. Selective lysis of the autologous tumor by delta TCS1+ gamma/delta+ tumor-infiltrating lymphocytes from human lung carcinomas.
    Zocchi MR, Ferrarini M, Rugarli C.
    Eur J Immunol; 1990 Dec 01; 20(12):2685-9. PubMed ID: 1702723
    [Abstract] [Full Text] [Related]

  • 17. Cytokines alter target cell susceptibility to lysis: I. Evaluation of non-major histocompatibility complex-restricted effectors reveals differential effects on natural and lymphokine-activated killing.
    Wiebke EA, Custer MC, Rosenberg SA, Lotze MT.
    J Biol Response Mod; 1990 Apr 01; 9(2):113-26. PubMed ID: 2111373
    [Abstract] [Full Text] [Related]

  • 18. Characterization of the CD4+ and CD8+ tumor infiltrating lymphocytes propagated with bispecific monoclonal antibodies.
    Wong JT, Pinto CE, Gifford JD, Kurnick JT, Kradin RL.
    J Immunol; 1989 Nov 15; 143(10):3404-11. PubMed ID: 2509557
    [Abstract] [Full Text] [Related]

  • 19. T cell clones expressing the natural killer cell-related p58 receptor molecule display heterogeneity in phenotypic properties and p58 function.
    Ferrini S, Cambiaggi A, Meazza R, Sforzini S, Marciano S, Mingari MC, Moretta L.
    Eur J Immunol; 1994 Oct 15; 24(10):2294-8. PubMed ID: 7925558
    [Abstract] [Full Text] [Related]

  • 20. Natural killer (NK)-like cytotoxic activity of allospecific T cell receptor-gamma,delta+ T cell clones. Distinct receptor-ligand interactions mediate NK-like and allospecific cytotoxicity.
    Koide J, Rivas A, Engleman EG.
    J Immunol; 1989 Jun 15; 142(12):4161-8. PubMed ID: 2470816
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.